83 FR 1622 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 9 (January 12, 2018)

Page Range		1622-1622
FR Document		2018-00444

Federal Register, Volume 83 Issue 9 (Friday, January 12, 2018)

[Federal Register Volume 83, Number 9 (Friday, January 12, 2018)]
[Notices]
[Page 1622]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-00444]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Development of Portable Neuromodulatory Devices for 
the Treatment of Substance Use Disorders (8941).
    Date: January 17, 2018.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Julia Berzhanskaya, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, Division of 
Extramural Research, National Institute on Drug Abuse, NIH, DHHS, 
6001 Executive Boulevard, Room 4234, MSC 9550, Bethesda, MD 20892, 
301-827-5840, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: January 9, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-00444 Filed 1-11-18; 8:45 am]
 BILLING CODE 4140-01-P

1622 Federal Register / Vol. 83, No. 9 / Friday, January 12, 2018 / Notices

Contact Person: Julia Berzhanskaya, Ph.D., Place: National Institutes of Health. DEPARTMENT OF HEALTH AND
Scientific Review Officer, Office of Lawton L. Chiles International House HUMAN SERVICES
Extramural Policy and Review, Division of (Stone House), Building 16, Conference
Extramural Research, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive Room, 16 Center Drive, Bethesda, MD National Institutes of Health
Boulevard, Room 4234, MSC 9550, Bethesda, 20892.
MD 20892, 301–827–5840, National Institute on Drug Abuse;
Open Session: February 13, 2018, 9:00
julia.berzhanskaya@nih.gov. Notice of Closed Meeting
a.m. to 3:00 p.m.
(Catalogue of Federal Domestic Assistance
Program No.: 93.279, Drug Abuse and Agenda: Update and discussion of Pursuant to section 10(d) of the
Addiction Research Programs, National current and planned FIC activities. Federal Advisory Committee Act, as
Institutes of Health, HHS) Contact Person: Kristen Weymouth, amended, notice is hereby given of the
Dated: January 9, 2018. Executive Secretary, Fogarty following meeting.
Natasha M. Copeland, International Center, National Institutes The meeting will be closed to the
Program Analyst, Office of Federal Advisory of Health, 31 Center Drive, Room public in accordance with the
Committee Policy. B2C02, Bethesda, MD 20892, (301) 496– provisions set forth in sections
[FR Doc. 2018–00445 Filed 1–11–18; 8:45 am] 1415, kristen.weymouth@nih.gov. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
BILLING CODE 4140–01–P as amended. The contract proposals and
Any interested person may file
the discussions could disclose
written comments with the committee
confidential trade secrets or commercial
DEPARTMENT OF HEALTH AND by forwarding the statement to the
property such as patentable material,
HUMAN SERVICES Contact Person listed on this notice. The
and personal information concerning
statement should include the name,
individuals associated with the contract
National Institutes of Health address, telephone number and when
proposals, the disclosure of which
applicable, the business or professional
Fogarty International Center; Notice of would constitute a clearly unwarranted
affiliation of the interested person.
Meeting invasion of personal privacy.
In the interest of security, NIH has
Pursuant to section 10(d) of the Name of Committee: National Institute on
instituted stringent procedures for
Federal Advisory Committee Act, as Drug Abuse Special Emphasis Panel,
entrance onto the NIH campus. All
amended, notice is hereby given of a Development of Portable Neuromodulatory
visitor vehicles, including taxicabs,
meeting of the Fogarty International Devices for the Treatment of Substance Use
hotel, and airport shuttles will be Disorders (8941).
Center Advisory Board. inspected before being allowed on
The meeting will be open to the Date: January 17, 2018.
campus. Visitors will be asked to show Time: 12:00 p.m. to 5:00 p.m.
public as indicated below, with one form of identification (for example,
attendance limited to space available. Agenda: To review and evaluate contract
a government-issued photo ID, driver’s proposals.
Individuals who plan to attend and
license, or passport) and to state the Place: National Institutes of Health,
need special assistance, such as sign
language interpretation or other purpose of their visit. Neuroscience Center, 6001 Executive
Information is also available on the Boulevard, Rockville, MD 20852, (Telephone
reasonable accommodations, should
Institute’s/Center’s home page: http:// Conference Call).
notify the Contact Person listed below
Contact Person: Julia Berzhanskaya, Ph.D.,
in advance of the meeting. www.fic.nih.gov/About/Advisory/Pages/
The meeting will be closed to the Scientific Review Officer, Office of
default.aspx, where an agenda and any
Extramural Policy and Review, Division of
public in accordance with the additional information for the meeting Extramural Research, National Institute on
provisions set forth in sections will be posted when available. Drug Abuse, NIH, DHHS, 6001 Executive
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
(Catalogue of Federal Domestic Boulevard, Room 4234, MSC 9550, Bethesda,
as amended. The grant applications
Assistance Program Nos. 93.106, MD 20892, 301–827–5840,
and/or contract proposals and the
Minority International Research julia.berzhanskaya@nih.gov.
discussions could disclose confidential
trade secrets or commercial property Training Grant in the Biomedical and This notice is being published less than 15
such as patentable material, and Behavioral Sciences; 93.154, Special days prior to the meeting due to the timing
personal information concerning International Postdoctoral Research limitations imposed by the review and
individuals associated with the grant Program in Acquired Immunodeficiency funding cycle.
applications and/or contract proposals, Syndrome; 93.168, International (Catalogue of Federal Domestic Assistance
the disclosure of which would Cooperative Biodiversity Groups Program No.: 93.279, Drug Abuse and
constitute a clearly unwarranted Program; 93.934, Fogarty International Addiction Research Programs, National
invasion of personal privacy. Research Collaboration Award; 93.989, Institutes of Health, HHS)
Name of Committee: Fogarty Senior International Fellowship Awards Dated: January 9, 2018.
International Center Advisory Board. Program, National Institutes of Health, Natasha M. Copeland,
Date: February 12–13, 2018. HHS) Program Analyst, Office of Federal Advisory
Place: National Institutes of Health Dated: January 9, 2018. Committee Policy.
Lawton L. Chiles International House [FR Doc. 2018–00444 Filed 1–11–18; 8:45 am]
Natasha M. Copeland,
sradovich on DSK3GMQ082PROD with NOTICES

(Stone House), Building 16, Conference
Program Analyst, Office of Federal Advisory BILLING CODE 4140–01–P
Room, 16 Center Drive, Bethesda, MD
20892. Committee Policy.
Closed Session: February 12, 2018, [FR Doc. 2018–00440 Filed 1–11–18; 8:45 am]
2:00 p.m. to 5:00 p.m. BILLING CODE 4140–01–P
Agenda: Second level review of grant
applications.
Date: February 13, 2018.

VerDate Sep<11>2014 17:47 Jan 11, 2018 Jkt 244001 PO 00000 Frm 00018 Fmt 4703 Sfmt 9990 E:\FR\FM\12JAN1.SGM 12JAN1

Document Created: 2018-10-26 09:50:38
Document Modified: 2018-10-26 09:50:38

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		January 17, 2018.
FR Citation		83 FR 1622

83 FR 1622 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 9 (January 12, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health